The Use of Diffuse Optical Spectroscopy to Characterize in Response to Weight-Loss Intervention
NCT ID: NCT02146885
Last Updated: 2022-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
21 participants
OBSERVATIONAL
2013-01-08
2017-01-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
NCT07239167
The Effect of Mild Weight Loss on Circulating Metabolite Profiles
NCT03135132
Identification of Muscle-specific Biomarkers of Fatty Acid Beta-oxidation
NCT01494025
Dietary Correlates of the Maximal Capacity for Fat Oxidation
NCT02070055
Effect of Weight Loss on Myocardial Metabolism and Cardiac Relaxation in Obese Adults
NCT00572624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Diffuse Optical Spectroscopy Imaging is a method for studying absorption and scattering (optical properties) of tissue in humans. It is related to near-infrared spectroscopy , but allows for more quantitative and thorough measurements. The researcher use Diffuse Optical Spectroscopy to measure fatty tissue, water, blood concentration level during weight loss program to determine the effect of sustained changes in weight or relapses.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Weight Control
Weight Control
Weight Control
Weight Control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Weight Control
Weight Control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participation in Weight Loss program
Exclusion Criteria
* Pregnancy or planned pregnancy during the course of the study period
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beckman Laser Institute University of California Irvine
OTHER
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beckman Laser Institute and Medical Center
Shaista Malik, M.D., Assistant Professor-Cardiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shaista Malik, MD
Role: PRINCIPAL_INVESTIGATOR
Beckman Laser Institute, UCI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beckman Laser Institute
Irvine, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20129158
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.